Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    Journal of medicinal chemistry 18 (1975), S. 523-524 
    ISSN: 1520-4804
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1998
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background. Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (〈 30 weeks), birth weights (〈 1250 g), or more complicated clinical courses. Objective. To determine if such strategies reduce detection of cystic periventricular leukomalacia (cPVL) and persistent ventricular enlargement (pVE) – late sonographic abnormalities highly predictive of adverse neurodevelopment in preterm infants. Methods. Timing, findings, and number of neurosonograms were reviewed for all survivors born at K 32 weeks' gestation at University Hospital, Denver, Colo., between January 1992 and June 1995. Results. Of 236 surviving infants, 61 (26 %) were never scanned, and 175 (74 %) had a total of 432 scans. Only 106 infants (45 %) had a neurosonogram on or after 28 days (timed to detect all cPVL/pVE). Eleven infants (4.7 %) had cPVL, and 19 (8 %) had pVE. Severity of clinical course did not predict development of cPVL, but was a better predictor of pVE. Initial neurosonograms were normal in 6/11 (55 %) with cPVL and 5/19 (26 %) with pVE. Screening declined from 86 % of infants in 1992 (average 2.54 neurosonograms each), to 64 % by 1994–1995 (average of 2.22 neurosonograms each). Infants 〉 30 weeks' gestation comprised 55 of 61 patients without any neurosonograms (90 %), 4 of 11 patients with cPVL (36 %), and 4 of 19 patients with pVE (21 %). Conclusion. Screening neurosonography has declined from 1992 to 1995, particularly in larger premature infants (30–32 weeks' gestation) who remain at risk for cPVL and pVE. Clinical course or results of initial studies do not always predict the development of these late abnormalities. We recommend that one neurosonogram be done at L 4 weeks of age in all premature infants K 32 weeks' gestation, regardless of birth weight, clinical course, or results of prior studies. An earlier neurosonogram should be obtained for infants 〈 30 weeks' gestation in the second week of life to detect complications of intracranial hemorrhage.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...